ArticleFrontiers in medicine2024

Postoperative adjuvant immunotherapy for pathological stage II-IVa esophageal squamous cell carcinoma after radical surgery does not improve disease-free recurrence rates.

Xihao Xie et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.